Accordingly, the main objective of this paper is to present perspectives toward a new direction for neurodegenerative disease therapy, and we review the literature in a focused manner to reveal interconnections between immunotherapy and “anti-insulin resistance” therapy relevant to AD, PD, and other age-related neurodegenerative conditions. This evidence concerns the gene INS and neurodegenerative disease.